About 1 in 4 pregnant women carry Group B Streptococcus bacteria that can be passed to their babies, resulting in 147,000+ infant deaths worldwide each year. Today, @US_FDA granted Breakthrough Therapy Designation for our maternal vaccine candidate: on.pfizer.com/3TMoOvr
@AlbertBourla | 58,152 followers
Replying to @AlbertBourla
With an estimated 410,000 GBS cases worldwide—the largest burden in low- and middle-income countries—we are pursuing a global clinical development strategy with the intent to make a successfully developed vaccine available worldwide as quickly as possible.

Engagement Map

Quotes
Replies
Retweets
Trendsmap

Replies and Quotes

Total of 4 replies and 2 quotes found
In reply to @AlbertBourla
Or they can be treated with antibiotics at delivery like they have been for decades
 
In reply to @AlbertBourla
Is this part of a plan to sow confusion about the GBS, Guillain-Barré Syndrome, caused by your existing injectable objectionables? Or just an unrelated new scam?
 
 
 
Over 2 replies and quotes not shown

Retweeters

No retweeters found
3 retweeters not shown
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.